Self-Funded Employer Health Plans Implications of Drug Price Transparency Strategies to Manage Medical Oncology Costs & Improve Care Quality Wes Chapman April 30, 2021 Introduction I have had the privilege of working with several self-funded employers and community based medical oncology physician groups over the last [...]
Read more
Oncology Drug Discovery Delivering Translational Excellence & Fulfilling the Promise of Individualized Care March 31, 2021 Wes Chapman Figure 1 Translation: “the process of turning observations in the laboratory, clinic, and community into interventions that improve the health of individuals and populations – from diagnostics and [...]
Read more
Nashville Property Tax Increase A Review of Public Documents Wes Chapman & Pepper Hatch September 16, 2020 Summary and Conclusions On April 28th, 2020 Metro Nashville provided an updated budget proposing a $332.7 million property tax increase in response to economic uncertainties related to COVID-19. [...]
Read more
COVID-19; What is Angela Merkel telling us? “We have to understand that many people will be infected, … The consensus among experts is that 60 to 70 percent of the population will be infected as long as this remains the situation.” Angela [...]
Read more
2018/2019 Oncology Drug FDA Approvals Notifications Implications for Early Phase Clinical Trials Dr. Wael Harb & Wes Chapman August 18, 2019 Illustration of an immune system T cell killing a cancer cell “complete response (kum-PLEET reh-SPONTS) "The disappearance of all signs of cancer in response to treatment. [...]
Read more